SILVER SPRING, Md., Nov. 6, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have...
from PR Newswire: https://ift.tt/32mj5TZ
No comments:
Post a Comment